Table 2.
Comparison of atherosclerosis markers on day 90.
| SGLT2i | p1 | Non-SGLT2i | p2 | p3 | |||
|---|---|---|---|---|---|---|---|
| SGLTi D N = 30 |
SGLT2i non-D N = 24 |
Non-SGLT2i D N = 34 |
Non-SGLT2i non-D N = 25 |
||||
| FMD (mm) | 0.3 ± 0.09 | 0.36 ± 0.15 | 0.07 | 0.21 ± 0.09 | 0.30 ± 0.11 | 0.02 | <0.001 |
| FMD% | 8.56 ± 2.81 | 9.58 ± 4.62 | 0.34 | 5.51 ± 2.33 | 8.01 ± 3.94 | 0.003 | <0.001 |
| CIMT (mm−1) | 6.34 ± 0.94 | 6.34 ± 1.36 | 0.99 | 6.50 ± 1.29 | 7.04 ± 1.68 | 0.17 | 0.14 |
CIMT = carotid intima media thickness, D = diabetic, FMD = flow mediated dilation, FMD% = FMD rate, p1 = difference between SGLT2i D and SGLT2i non-D groups, p2 = difference between non-SGLT2i D and non-SGLT2i non-D groups, p3 = difference between SGLT2i and non-SGLT2i groups, SGLT2i = sodium glucose cotransporter 2 inhibitors (group designation).